U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2015
471
Name Type Language
DINUTUXIMAB
DASH   INN   USAN   WHO-DD  
USAN   INN  
Official Name English
dinutuximab [INN]
Common Name English
CH14.18-UTC
Code English
CH14.18
Code English
DINUTUXIMAB [PURPLE BOOK CDER]
Common Name English
CHIMERIC ANTI-DISIALOGANGLIOSIDE (GD2) MONOCLONAL ANTIBODY (CH14.18/CHO)
Common Name English
CH-14.18
Code English
APN-311
Code English
UNITUXIN
Brand Name English
CH-1418
Code English
DINUTUXIMAB [JAN]
Common Name English
DINUTUXIMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 LIGHT CHAIN, DIMER
Common Name English
DINUTUXIMAB [USAN]
Common Name English
CH1418
Code English
CH-14.18-UTC
Code English
Dinutuximab [WHO-DD]
Common Name English
APN311
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 377712
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
NCI_THESAURUS C155653
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
FDA ORPHAN DRUG 324210
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
EMA ASSESSMENT REPORTS UNITUXIN (AUTHORIZTION: NEUROBLASTOMA)
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
NDF-RT N0000191500
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
WHO-ATC L01XC16
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
Code System Code Type Description
CAS
1613303-02-8
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
ALTERNATIVE
MERCK INDEX
m11838
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
CHEMBL
CHEMBL2109420
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
DRUG BANK
DB09077
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
RXCUI
1606274
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY RxNorm
FDA UNII
7SQY4ZUD30
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
WIKIPEDIA
Dinutuximab
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
LACTMED
Dinutuximab
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
DRUG CENTRAL
4948
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
CAS
1363687-32-4
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
NDF-RT
N0000191499
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY Glycolipid Disialoganglioside-directed Antibody Interactions [MoA]
SMS_ID
100000156453
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
EVMPD
SUB130362
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
ChEMBL
CHEMBL3137342
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
IUPHAR
7979
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
INN
9754
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
NCI_THESAURUS
C1570
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
DAILYMED
7SQY4ZUD30
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
USAN
AB-125
Created by admin on Sat Dec 16 09:31:27 GMT 2023 , Edited by admin on Sat Dec 16 09:31:27 GMT 2023
PRIMARY
ACTIVE MOIETY
DINUTUXIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966